HGH Frag 176-191

HGH Frag 176-191 is supplied as a research-grade lyophilised peptide for in-vitro laboratory use only. C-terminal hGH fragment — lipolysis research. Every lot is released against identity and ≥ 99 % HPLC purity, with a lot-specific Certificate of Analysis available on request.

Every HGH Frag 176-191 lot is released against identity and ≥ 99 % HPLC purity, with mass-spectrometry confirmation and a lot-specific Certificate of Analysis (CoA) made available with the order. Synthesis, lyophilisation and lot release all happen in our Carlsbad, California facility — no third-party fulfilment.

HGH Frag 176-191 is supplied in a single 5 mg vial. All vials are lyophilised for shelf stability and reconstituted in the laboratory before use.

Lyophilised: store at –20 °C, protected from light, up to 24 months. Reconstituted: keep at 2–8 °C and use within 14 days.

Reconstitute with bacteriostatic water (1–3 ml depending on the working concentration). Add slowly down the vial wall, then swirl gently — do not shake or vortex.

No. HGH Frag 176-191 is sold strictly for in-vitro research use by verified laboratories and licensed healthcare professionals. It is not for human consumption, veterinary use, or any clinical application. Buyers are responsible for compliance with their local regulations.